Bibliografía del artículo
1. Queenan AM, Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 20:440-458, 2007.
2. Walsh TR, Toleman MA, Poirel L, et al. Metallo-beta-lactamases: the quiet before the storm? Clin Microbiol Rev 18:306-325, 2005.
3. Deshpande LM, Jones RN, Fritsche TR, et al. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb Drug Resist 12:223-230, 2006.
4. Pournaras S, Ikonomidis A, Tzouvelekis LS, et al. VIM-12, a novel plasmid-mediated metallo-beta-lactamase from Klebsiella pneumoniae that resembles a VIM-1/VIM-2 hybrid. Antimicrob Agents Chemother 49:5153-5156, 2005.
5. Giakkoupi P, Xanthaki A, Kanelopoulou M, et al. VIM-1 Metallo-betalactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 41:3893-3896, 2003.
6. Aschbacher R, Doumith M, Livermore DM, et al. Linkage of acquired quinolone resistance (qnrS1) and metallo-beta-lactamase (blaVIM-1) genes in multiple species of Enterobacteriaceae from Bolzano, Italy. J Antimicrob Chemother 61:515-523, 2008.
7. Weile J, Ohler S, Schonthal S, et al. A VIM-1 metallo-beta-lactamase-producing-Klebsiella pneumoniae clinical isolate in an acute hospital in Germany. Int J Antimicrob Agents 33:389-391, 2009.
8. Tortola MT, Lavilla S, Miro E, et al. First detection of a carbapenem-hydrolyzing metalloenzyme in two Enterobacteriaceae isolates in Spain. Antimicrob Agents Chemother 49:3492-3494, 2005.
9. Tato M, Coque TM, Ruiz-Garbajosa P, et al. Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis 45:1171-1178, 2007.
10. Psichogiou M, Tassios PT, Avlamis A, et al. Ongoing epidemic of bla-VIM-1-positive Klebsiella pneumoniae in Athens, Greece: a prospective survey. J Antimicrob Chemother 61:59-63, 2008.
11. Kassis-Chikhani N, Decre D, Gautier V et al. First outbreak of multidrug-resistant Klebsiella pneumoniae carrying blaVIM-1 and blaSHV-5 in a French university hospital. J Antimicrob Chemother 57:142-145, 2006.
12. Ktari S, Arlet G, Mnif B, et al. Emergence of multidrug-resistant Klebsiella pneumoniae isolates producing VIM-4 metallo-beta-lactamase, CTX-M-15 extended-spectrum beta-lactamase, and CMY-4 AmpC beta-lactamase in a Tunisian university hospital. Antimicrob Agents Chemother 50:4198-4201, 2006.
13. Galani I, Rekatsina PD, Hatzaki D, et al. Evaluation of different laboratory tests for the detection of metallo-beta-lactamase production in Enterobacteriaceae. J Antimicrob Chemother 61:548-553, 2008.
14. Picao RC, Andrade SS, Nicoletti AG, et al. Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol 46:2028-2037, 2008.
15. Castanheira M, Sader H, Deshpande, L et al. Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and Metallo-beta-lactamase-producing Enterobacteriaceae. Report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother 52:570-573, 2008.
16. Conejo MC, Hernandez JR, Pascual A. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases. Diagn Microbiol Infect Dis 61:343-345, 2008.
17. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 19th Informational Supplement. CLSI Document M100-S19. Wayne, PA: CLSI, 2009.
18. Nordmann P, Poirel L. Emerging carbapenemases in Gram-negative
aerobes. Clin Microbiol Infect 8:321-331, 2002.
19. Coque TM, Oliver A, Pérez-Díaz JC, et al. Genes encoding TEM-4, SHV-2, and CTX-M-10 extended-spectrum beta-lactamases are carried by multiple Klebsiella pneumoniae clones in a single hospital (Madrid, 1989 to 2000). Antimicrob Agents Chemother 46:500-510, 2002.
20. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed- field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239, 1995.
21. Gulmez D, Woodford N, Palepou MF et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 31:523-526, 2008.
22. Hong T, Smith Moland E, Abdalhamid B et al. Escherichia coli: development of carbapenem resistance during therapy. Clin Infect Dis 40:84-86, 2005.
23. Giakkoupi P, Tzouvelekis LS, Daikos GL et al. Discrepancies and interpretation problems in susceptibility testing of VIM-1-producing Klebsiella pneumoniae isolates. J Clin Microbiol 43:494-496, 2005.
24. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 20th Informational Supplement. CLSI Document M100-S20. Wayne, PA: CLSI, 2010.
25. Cobo J, Morosini MI, Pintado V et al. Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta-lactamase-producing Klebsiella pneumoniae epidemic clone. Diagn Microbiol Infect Dis 60:319-322, 2008.
26. Daly MW, Riddle DJ, Ledeboer NA et al. Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae. Pharmacotherapy 27:1052-1057, 2007.
27. Anthony KB, Fishman NO, Linkin DR et al. Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecycline. Clin Infect Dis 2008; 46:567-570, 2008.
28. Kelesidis T, Karageorgopoulos DE, Kelesidis I et al. Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies. J Antimicrob Chemother 62:895-904, 2008.
29. Keeney D, Ruzin A, Bradford PA. RamA, a transcriptional regulator, and AcrAB, an RND-type efflux pump, are associated with decreased susceptibility to tigecycline in Enterobacter cloacae. Microb Drug Resist 13:1-6, 2007.
30. Rasheed JK, Jay C, Metchock B et al. Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia. Antimicrob Agents Chemother 41:647-653, 1997.
31. Fishman JA. Infection in renal trasplant recipients. Semin Nephrol 27:445-461, 2007.